Based on in vitro findings, PPARγ ligands were tested in murine breast cancer xenograft models where they proved to be effective in counteracting tumor growth, without inducing toxic effects either in combined PPARγ/RXR treatments or alone compared to controls [34,41,42]. Here, PPARG is linked to breast cancer.